stockrowBioNTech SE Sponsored ADR (BNTX) vs Genmab A/S Sponsored ADR (GMAB)
- BioNTech SE Sponsored ADR BNTX 86.95 +1.27%
- Genmab A/S Sponsored ADR GMAB 52.87 +0.25%
BioNTech SE Sponsored ADR and Genmab A/S Sponsored ADR are both Biotechnology companies. Genmab A/S Sponsored ADR is the larger, with a market value of $31.5B against $21.6B — 1.5× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Genmab A/S Sponsored ADR trades at 41.7×. Genmab A/S Sponsored ADR grew revenue faster over the last twelve months: 22.3% against −22.7%. Genmab A/S Sponsored ADR has the higher net margin (19.1% vs −63.8%) and the higher return on invested capital (6.99% vs −34.3%). Across the 19 metrics below, Genmab A/S Sponsored ADR leads on 12 and BioNTech SE Sponsored ADR on 7.
Valuation
Profitability
| Metric | BNTX | GMAB | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.59% | 93.03% | 65.16% |
| Operating margin | (78.99%) | 25.95% | 0.00% |
| Net margin | (63.77%) | 19.08% | 0.00% |
| Free cash flow margin | (19.21%) | (153.64%) | 0.00% |
| Return on equity | (8.29%) | 14.00% | (50.12%) |
| Return on assets | (7.22%) | 8.30% | (45.60%) |
| Return on invested capital | (34.28%) | 6.99% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack